Bristol-Myers Squibb Company
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2006 | — | — | $2.02B |
| FY2007 | — | — | $1.80B |
| FY2008 | $6.59B | $12.24B | $7.98B |
| FY2009 | $6.13B | $14.84B | $7.83B |
| FY2010 | $5.33B | $15.71B | $5.14B |
| FY2011 | $5.28B | $15.90B | $3.41B |
| FY2012 | $5.27B | $16.25B | $2.31B |
| FY2013 | $7.18B | $13.70B | $1.36B |
| FY2014 | $7.37B | $15.53B | $5.23B |
| FY2015 | $7.13B | $15.69B | $6.29B |
| FY2016 | $5.72B | $14.55B | $2.64B |
| FY2017 | $7.24B | $14.54B | $3.91B |
| FY2018 | $5.78B | $12.91B | $5.34B |
| FY2019 | $5.64B | $15.32B | $7.34B |
| FY2020 | $46.11B | $49.98B | $15.82B |
| FY2021 | $39.61B | $35.95B | $13.98B |
| FY2022 | $35.06B | $31.06B | $9.12B |
| FY2023 | $36.65B | $29.43B | $11.46B |
| FY2024 | $47.60B | $16.34B | $10.35B |
| FY2025 | $42.85B | $18.47B | $10.21B |